Dental Biomaterials Market worth $9.6 Billion by 2023 – MarketsandMarkets

The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth.

The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. Based on the type, the market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the largest share in 2018. The large share of this segment can be attributed to the increasing penetration of dental implants and the wide applications of metallic biomaterials in dentistry.

Sample Report – https://www.marketsandmarkets.com/requestsampleNew.asp?id=198160556

Based on the end user, the market is segmented into the dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes. In 2018, the dental implant and prosthetic manufacturers segment accounted for the largest of the dental biomaterials market. The large share of this segment can be attributed to the increasing penetration of dental implants and prosthetics, growing adoption of CAD/CAM systems in dental clinics and laboratories, increasing number of dental practices, and the rising awareness on oral diseases.

Download Free PDF – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198160556

Key Market Players

The prominent players in the global market are Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).